The GlycoVision platform offers new insights into cellular and protein function through characterization of glycoproteins. The key advantage of investigating the glycoproteome, as compared to the proteome, is that it provides access to a layer of biology, post-translational glycosylation, which importantly affects protein function in health and disease, adding orders of magnitude richer information about biology. GlycoVision is the first commercially available platform capable of rapidly and comprehensively interrogating glycosylation across the proteome, hypothesis-free or targeted, from serum, plasma, or tissue.